Acuamark Diagnostics Raises $11.3M in Series A Funding
Summary
With the Series A proceeds, the company intends to scale its sample collections and add a number of key building blocks to its organization. Led by Co-founder and CEO Dr. Bernard Peperstraete, AcuamarkDx is a biotechnology company focused on developing innovative technology for improved and cost-effective blood-based early-cancer screening for single cancer early detection and multi-cancer early detection. * Claudio Del Vecchio is an international business entrepreneur and industry leader. The Del Vecchio family founded the Luxottica Group where Mr. Del Vecchio was an Executive Board Director for several years, ran its US operations, and oversaw its public offering on the New York Stock Exchange. Subsequently, Mr. Del Vecchio acquired Brooks Brothers which he ran for 20 years until the COVID Pandemic.